Thymosin Alpha-1 Research Peptide: A Master Regulator for Immunology and Oncology Studies

If your laboratory focuses on immune modulation, viral pathogenesis or cancer immunotherapy, you already understand the need for well-characterised molecular tools. Thymosin Alpha-1 research peptide (Tα1, thymalfasin) is a naturally occurring 28‑amino‑acid polypeptide first isolated from the thymus gland in 1977. As the first biologically active peptide identified in the thymic preparation, fraction 5, it has since become a cornerstone for studying T‑cell differentiation, immune restoration and the complex interplay between innate and adaptive immunity.

At Wuhan Top Miracle Peptides, we supply high-purity Thymosin Alpha-1 research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy and the USA. Every batch is synthesised using solid‑phase peptide synthesis (SPPS), purified by preparative HPLC and validated by mass spectrometry to meet the rigorous quality standards demanded by the research community. Each shipment includes a Certificate of Analysis (COA) confirming ≥99% purity, ensuring your studies into immune reconstitution, infectious disease or tumour immunology begin with uncompromising quality.

What Makes Thymosin Alpha-1 a Highly Versatile Research Tool?

Unlike many immunomodulators that target a single cell type or pathway, Thymosin Alpha-1 research peptide exhibits true pleiotropy. It interacts with multiple components of the immune system, enhancing both innate and adaptive responses without triggering the uncontrolled inflammation associated with some immune agonists.

A Naturally Occurring Peptide with Broad-Reaching Activity

The sequence of Tα1 is highly conserved across mammalian species, reflecting its fundamental role in immune homeostasis. Its synthetic form, thymalfasin, has been approved by regulatory agencies in over 35 countries for the treatment of hepatitis B and as an immune enhancer in immunocompromised populations.

Molecular characteristics of Thymosin Alpha-1:

• Structure: A highly conserved 28‑amino‑acid acetylated polypeptide.

• Source: Naturally produced by thymic epithelial cells and also found in spleen, lymph nodes, lung, kidney and brain.

• Biological relevance: The deacetylated form exhibits substantially reduced activity, highlighting the importance of maintaining the correct modification during synthesis.

Mechanism of Action: From Toll‑Like Receptors to T‑Cell Function

The immunomodulatory activity of Thymosin Alpha-1 research peptide operates through several well‑characterised pathways:

• Toll‑Like Receptor (TLR) Activation: Tα1 signals through TLR2 and TLR9 on innate immune cells, leading to activation of the NF‑κB pathway and downstream cytokine production.

• T‑Cell Maturation and Differentiation: The peptide enhances T‑cell function, increases the CD4+/CD8+ ratio and blocks steroid‑induced apoptosis of thymocytes.

• Cytokine and Chemokine Modulation: It up‑regulates Th1‑type cytokines (including IFN‑γ) while suppressing excessive pro‑inflammatory mediators, restoring immune balance in chronic infection models.

• Macrophage Repolarisation: Tα1 can reprogram tumour‑associated macrophages (TAMs) from an M2‑like (pro‑tumoural) toward an antitumoral phenotype.

Chemical & Physical Specifications

Accurate characterisation of Thymosin Alpha-1 research peptide is essential for reproducible experimental design.

Key Research Applications for Thymosin Alpha‑1

Thymosin Alpha-1 research peptide has been extensively investigated across a wide range of research areas, supported by more than 30 clinical trials involving over 11,000 human subjects.

1. Immunology and T‑Cell Differentiation

The most fundamental role of Tα1 lies in its ability to restore immune competence. Research demonstrates that Thymosin Alpha-1 research peptide enhances the activity of T cells, dendritic cells (DCs) and natural killer (NK) cells while modulating cytokine and chemokine production. In hematopoietic models, Tα1 promotes the differentiation of stem cells into functional CD28+ T‑cells, offering a tool for studying thymic involution and age‑related immune decline.

2. Viral Hepatitis and Infectious Disease

Tα1 has been studied extensively in models of viral hepatitis. In hepatitis B virus‑related acute‑on‑chronic liver failure (HBV‑ACLF), Tα1 improves clinical outcomes by rebalancing the immune response—mitigating excessive inflammation while preventing immune paralysis through modulation of T‑cell differentiation and cytokine production. The peptide has also demonstrated activity against HIV‑1, human T‑lymphotropic virus and human cytomegalovirus (HCMV) in vitro.

3. Oncology and Immuno‑Oncology Research

The immunomodulatory properties of Thymosin Alpha-1 research peptide are increasingly being explored in cancer research. Key findings include:

• Non‑Small Cell Lung Cancer (NSCLC): A phase II trial is investigating Tα1 as an adjunct to concurrent chemoradiotherapy and consolidative immunotherapy for locally advanced NSCLC.

• Breast Cancer: Case reports describe combinations of Tα1 with stereotactic body radiotherapy and immune checkpoint inhibitors in metastatic breast cancer.

• Macrophage Repolarisation: Tα1 reverses oncolytic adenovirus‑induced M2 polarisation of tumour‑associated macrophages, improving antitumour immunity and therapeutic efficacy.

• Immune Reconstitution: In a phase I/II trial, Tα1 promoted immune reconstitution and improved survival in recipients of HLA‑matched sibling T‑cell‑depleted stem cell transplants.

4. COVID‑19 and Vaccine Research

During the COVID‑19 pandemic, Thymosin Alpha-1 research peptide was evaluated as an add‑on treatment for moderate‑to‑severe COVID‑19. A double‑blind, multicentre, randomised, placebo‑controlled phase III study provided evidence that Tα1 lowers mortality rates in severe COVID‑19 patients, reduces hospitalisation duration and accelerates recovery. Ongoing trials are examining Tα1 as an enhancer of vaccine response among older adults receiving booster doses of COVID‑19 vaccine.

5. Immune Deficiencies and Vaccine Response

Due to its ability to augment Th1 immune responses, Tα1 has been used in research models of primary and secondary immunodeficiencies, including AIDS. It is also studied for its capacity to restore depressed vaccine responses in immunocompromised populations.

Reconstitution & Handling Protocol

Thymosin Alpha-1 research peptide is supplied as a lyophilised powder. Proper reconstitution is critical for maintaining its structural integrity and biological activity.

Step 1 – Preparation

• Bring the sealed Tα1 vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5–7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the Tα1 vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A typical starting concentration is 1–2 mg per 0.5–1.0 mL of BAC water, yielding a 2 mg/mL solution.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted Tα1 into single‑use sterile vials.

• Store aliquots at –20°C. Prevent repeated freeze‑thaw cycles.

• Once thawed, store at 2–8°C and use within 7 days. For longer storage beyond 7 days, maintain frozen at –20°C.

Concentration Reference Table

*Adjust diluent volume based on your experimental requirements. Tα1 is soluble in water at concentrations up to at least 2 mg/mL.*

Storage & Stability Guidelines

Why Choose Wuhan Top Miracle Peptides for Thymosin Alpha‑1 (Tα1)?

As an authentic licensed peptide supplier based in the United Kingdom, we supply Thymosin Alpha-1 research peptide and a wide range of research-grade peptides under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T principles (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥99% for every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised in ISO 13485:2016 and GMP‑certified facilities, ensuring batch‑to‑batch consistency.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories and wholesale buyers across the UK, EU and USA with flexible volume pricing and reliable logistics.

• UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United Kingdom—including those at leading institutions in London, Cambridge, Oxford, Manchester and Edinburgh—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: Thymosin Alpha-1 Research Peptide

What is Thymosin Alpha-1 research peptide?
Thymosin Alpha-1 research peptide (Tα1, thymalfasin) is a 28‑amino‑acid acetylated polypeptide naturally produced by thymic epithelial cells. It is a well‑established immunomodulator used in research to study T‑cell differentiation, immune restoration and antiviral responses.

What is the sequence and molecular weight of Thymosin Alpha-1?
The sequence is Ac‑Ser‑Asp‑Ala‑Ala‑Val‑Asp‑Thr‑Ser‑Ser‑Glu‑Ile‑Thr‑Thr‑Lys‑Asp‑Leu‑Lys‑Glu‑Lys‑Lys‑Glu‑Val‑Val‑Glu‑Glu‑Ala‑Glu‑Asn‑OH. Its molecular weight is approximately 3108.28 g/mol.

What are the primary research applications of Thymosin Alpha-1?
Tα1 is widely studied in immunology and T‑cell differentiation, viral hepatitis and infectious disease research, oncology and immuno‑oncology (particularly NSCLC and breast cancer), COVID‑19 and vaccine response enhancement, and primary/secondary immune deficiencies.

 What purity does your Thymosin Alpha-1 research peptide meet?
Our Thymosin Alpha-1 research peptide is tested to ≥99% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

 How should I reconstitute Thymosin Alpha-1?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5–7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. A typical concentration is 2 mg/mL.

How should I store reconstituted Thymosin Alpha-1?
Reconstituted Tα1 should be stored at 2–8°C and used within 7 days. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Adding a carrier protein (0.1% HSA or BSA) is recommended for long‑term storage. Avoid repeated freeze‑thaw cycles.

Is Thymosin Alpha-1 research peptide legal to purchase in the UK?
Yes. Thymosin Alpha-1 is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess and use in the United Kingdom for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims.

Does Wuhan Top Miracle Peptides ship internationally?
Yes. We ship across the EU (France, Germany, Spain, Sweden, Italy) and to the USA from our UK warehouse. Wholesale pricing is available for bulk orders.

Wholesale Thymosin Alpha-1 Supply Across the UK and Europe

Wuhan Top Miracle Peptides supports wholesale peptide buyers in the United Kingdom and international markets.

We Ship To:

• United Kingdom
• France
• Germany
• Spain
• Sweden
• Italy
• USA
• Wider Europe

For larger Thymosin Alpha-1 orders, contact our team before checkout. This helps confirm stock, wholesale pricing, documentation, shipping options, and order handling.

Where to Buy Thymosin Alpha-1 in the UK

If you are searching for where to buy Thymosin Alpha-1 in the UK, Wuhan Top Miracle Peptides provides a simple process for research-focused and wholesale buyers.

How to Order

1. Review the Thymosin Alpha-1 product details.
2. Check the current product label and batch information.
3. Contact our team for availability.
4. Ask about wholesale pricing and COA information.
5. Confirm your shipping country.
6. Place your enquiry with support from our team.

 

 

Bulk Peptides Page
Shipping & Returns Page
Contact Us Page
Shop Page
Google Search Central
GOV.UK / MHRA
ASA / CAP Code Section 12
PubChem / NCBI / PubMed reference page

From fundamental studies of T‑cell maturation and immune reconstitution to translational models of viral hepatitis, COVID‑19 and cancer immunotherapy, Thymosin Alpha-1 research peptide provides a well‑characterised, pleiotropic platform for advanced immunology research. Its ability to signal through TLR2 and TLR9, modulate Th1 cytokine profiles and repolarise tumour‑associated macrophages—supported by over 30 clinical trials and decades of peer‑reviewed literature—makes it an essential tool for any laboratory investigating the immune system.

By choosing high‑purity, lab‑verified Thymosin Alpha-1 research peptide from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility and scientific integrity.

Ready to advance your immunology research with Thymosin Alpha-1? Browse our product catalogue, request a wholesale quote or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade Tα1 delivered directly to your facility in the UK, EU or USA.